Greater Boston
Part of Y Combinator Summer 2023 cohort Mavenbio.io
NeuFera is pioneering small-molecule therapeutics with a potential to transform the lives of heart-failure patients. Learn more at NeuCures.com
Part of McKinsey Digital Practice - serve clients in digital and strategy topics across industries, including financial services, payments, telecom, utilities, and food products.
NeuTrace is building an AI/ML-based Cardiac electrophysiology diagnostic and treatment system, by combining the power of in-procedure & EHR data, expert guidance, and 30+ years of basic medical research on fundamentals of abnormal heart rhythms. NeuTrace was acquired by Anumana in 2022.
Growth strategy consulting firm focused on helping the leaders of Global 1000 companies to design and create the future, instead of being disrupted by it.